Current Technical Analysis and interactive chart for $PGNX stock / shares. See the current PGNX Ideas on StockTwits · PGNX Tweets on Twitter. Indicators PGNX | Complete Progenics Pharmaceuticals Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview. Progenics Pharmaceuticals Inc. individual insider activity by MarketWatch. View the latest news on PGNX company insiders for their impact on company ****PGNX (T/$14) neuroendocrine tumor affects the hormone-producing cells of the body's neuroendocrine system that comprises of cells which are a Progenics Pharmaceuticals (PGNX), XBiotech (XBIT), Axovant Sciences ( AXON), TherapeuticsMD (TXMD), Ocular Therapeutix (OCUL), Calithera Biosciences
PGNX: Progenics Pharmaceuticals Inc - CNBC
PGNX. Progenics Pharmaceuticals Inc. LULU. lululemon athletica inc. XLF. SPDR Select Sector Fund – Finan. UGAZ. VelocityShares 3X Long Natural. NUGT. Follow Us! StockTwits Twitter · ETF Daily News. Toggle navigation PGNX · Progenics Pharmaceuticals Inc, 0.19%. ZIOP · ZIOPHARM Oncology Inc, 0.18%. 2/17, 87, +, 6.37 | 1.89, Progenics Pharmaceuticals Inc. PGNX, 4.25, +7.3, 3.83 - 4.51, 28231. (Strong) Bearish Trend. The closing price is below the upper limit
Progenics Pharmaceuticals - PGNX - Stock Price & News ...
Progenics Pharmaceuticals Inc. (PGNX) Income Statement ... Get the detailed quarterly/annual income statement for Progenics Pharmaceuticals Inc. (PGNX). Find out the revenue, expenses and profit or loss over the last fiscal year. PGNX Conversations From StockTwits - StockNews
PGNX | Complete Progenics Pharmaceuticals Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.
DVAX Dynavax Technologies Corporation - Stocktwits Dynavax Technologies Corporation. DVAX 6.12 0.03 (0.49%). NASDAQ Updated Jun 8, 2020 11:59 PM
Progenics Pharmaceuticals Inc. (PGNX) Stock Message Board ...
PGNX Stock Summary. With a price/sales ratio of 9.28, Progenics Pharmaceuticals Inc has a higher such ratio than 87.8% of stocks in our set. With a year-over-year growth in debt of -10.16%, Progenics Pharmaceuticals Inc's debt growth rate surpasses only 20.34% of about US stocks.